Polyacrylamide Gel Injection for Treatment of Human Immunodeficiency Virus-Associated Facial Lipoatrophy: 18 Months Follow-Up

By RAUSO RAFFAELE   FREDA NICOLA   PARLATO VINCENZO   GHERARDINI GIULIO   AMORE ROBERTO   TARTARO GIANPAOLO  

Dermatologic Surgery, Vol. 37, Iss. 11, 2011-11 ,pp. : 1584-1589

Elsevier

Access to resources Recommend Favorite

Human Immunodeficiency Virus–Associated Lipohypertrophy (Buccal Fat Pad Lipoma-Like Lesions) Reduced with Subcutaneously Injected Sodium Deoxycholate

By ROTUNDA ADAM M.   JONES DEREK H.  

Dermatologic Surgery, Vol. 36, Iss. 8, 2010-08 ,pp. : 1348-1354

Elsevier

Access to resources Recommend Favorite

Lopinavir/ritonavir in the treatment of human immunodeficiency virus infection

By Kaplan Susan S   Hicks Charles B  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 9, 2005-08 ,pp. : 1573-1585

Informa Healthcare

Access to resources Recommend Favorite

Abacavir and lamivudine for the treatment of human immunodeficiency virus

By Rizzardini Giuliano   Zucchi Patrizia  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 13, 2011-09 ,pp. : 2129-2138

Informa Healthcare

Access to resources Recommend Favorite

Prognostic factors for advanced-stage human immunodeficiency virus-associated classical Hodgkin lymphoma treated with doxorubicin, bleomycin, vinblastine, and dacarbazine plus combined antiretroviral therapy: A multi-institutional retrospective study

By Castillo Jorge J.   Bower Mark   Brühlmann Jérémy   Novak Urban   Furrer Hansjakob   Tanaka Paula Y.   Besson Caroline   Montoto Silvia   Cwynarski Kate   Abramson Jeremy S.   Dalia Samir   Bibas Michele   Connors Joseph M.   Furman Michael   Nguyen Minh-Ly   Cooley Timothy P.   Beltran Brady E.   Collins Jaime A.   Vose Julie M.   Xicoy Blanca   Ribera Josep-Maria   Castillo Jorge J.  

Cancer, Vol. 121, Iss. 3, 2015-02 ,pp. : 423-431

Blackwell Publishing

Access to resources Recommend Favorite